GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TCM Biotech International Corp (ROCO:4169) » Definitions » Price-to-Owner-Earnings

TCM Biotech International (ROCO:4169) Price-to-Owner-Earnings : (As of Sep. 21, 2024)


View and export this data going back to 2012. Start your Free Trial

What is TCM Biotech International Price-to-Owner-Earnings?

As of today (2024-09-21), TCM Biotech International's share price is NT$60.10. TCM Biotech International does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for TCM Biotech International's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of TCM Biotech International was 494.14. The lowest was 25.51. And the median was 228.53.


ROCO:4169's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 34.375
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-09-21), TCM Biotech International's share price is NT$60.10. TCM Biotech International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was NT$0.34. Therefore, TCM Biotech International's PE Ratio for today is 176.76.

As of today (2024-09-21), TCM Biotech International's share price is NT$60.10. TCM Biotech International's EPS without NRI for the trailing twelve months (TTM) ended in was NT$0.33. Therefore, TCM Biotech International's PE Ratio without NRI for today is 182.12.

During the past 13 years, TCM Biotech International's highest PE Ratio without NRI was 952.20. The lowest was 33.35. And the median was 68.80.


TCM Biotech International Price-to-Owner-Earnings Historical Data

The historical data trend for TCM Biotech International's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TCM Biotech International Price-to-Owner-Earnings Chart

TCM Biotech International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 292.48 - 56.04 -

TCM Biotech International Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 56.04 - - -

Competitive Comparison of TCM Biotech International's Price-to-Owner-Earnings

For the Biotechnology subindustry, TCM Biotech International's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TCM Biotech International's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TCM Biotech International's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where TCM Biotech International's Price-to-Owner-Earnings falls into.



TCM Biotech International Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

TCM Biotech International's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=60.10/-0.92
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TCM Biotech International  (ROCO:4169) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


TCM Biotech International Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of TCM Biotech International's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


TCM Biotech International Business Description

Traded in Other Exchanges
N/A
Address
No. 97, Sec. 1, Xintai 5th Road, Xizhi District, Neihu District, Taipei, TWN, 221
TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in the research and development of therapeutics for the prevention and treatment of liver diseases. Its products includes Anti-adhesion System, Anti-neoplastic agents, Osteoporosis Treatment Preparation, Iron Preparations, Osteoarthritis (OA) Treatment Products, Urinary System Treatment Products and others. The company has a business presence in Taiwan and other international countries such as the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines and China. The entity derives key revenue from the sales of multiple medical products which includes medicine, medical device, functional food and others.

TCM Biotech International Headlines

No Headlines